Fort LP’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $351K | Sell |
1,776
-128
| -7% | -$23.9K | 0.89% | 8 |
|
|
2024
Q2 | $327K | Buy |
1,904
+51
| +3% | +$8.45K | 0.84% | 20 |
|
|
2024
Q1 | $337K | Sell |
1,853
-197
| -10% | -$34K | 0.85% | 16 |
|
|
2023
Q4 | $318K | Sell |
2,050
-81
| -4% | -$11.8K | 0.79% | 19 |
|
|
2023
Q3 | $318K | Buy |
2,131
+41
| +2% | +$6.02K | 0.88% | 18 |
|
|
2023
Q2 | $282K | Sell |
2,090
-43
| -2% | -$6.31K | 0.74% | 57 |
|
|
2023
Q1 | $340K | Sell |
2,133
-774
| -27% | -$118K | 0.88% | 15 |
|
|
2022
Q4 | $470K | Sell |
2,907
-1,013
| -26% | -$155K | 0.71% | 13 |
|
|
2022
Q3 | $526K | Sell |
3,920
-2,917
| -43% | -$419K | 0.66% | 20 |
|
|
2022
Q2 | $1.05M | Sell |
6,837
-5,073
| -43% | -$775K | 0.71% | 3 |
|
|
2022
Q1 | $1.93M | Sell |
11,910
-1,364
| -10% | -$198K | 0.73% | 3 |
|
|
2021
Q4 | $1.8M | Sell |
13,274
-1,149
| -8% | -$136K | 0.58% | 29 |
|
|
2021
Q3 | $1.56M | Sell |
14,423
-1,632
| -10% | -$186K | 0.52% | 59 |
|
|
2021
Q2 | $1.81M | Sell |
16,055
-1,625
| -9% | -$183K | 0.52% | 52 |
|
|
2021
Q1 | $1.91M | Buy |
17,680
+298
| +2% | +$31.9K | 0.54% | 42 |
|
|
2020
Q4 | $1.86M | Buy |
17,382
+3,574
| +26% | +$343K | 0.56% | 17 |
|
|
2020
Q3 | $1.21M | Buy |
13,808
+1,190
| +9% | +$112K | 0.51% | 64 |
|
|
2020
Q2 | $1.24M | Sell |
12,618
-21,221
| -63% | -$1.87M | 0.67% | 10 |
|
|
2020
Q1 | $2.58M | Buy |
33,839
+2,069
| +7% | +$176K | 0.58% | 25 |
|
|
2019
Q4 | $2.81M | Buy |
31,770
+12,359
| +64% | +$1.03M | 0.5% | 68 |
|
|
2019
Q3 | $1.47M | Buy |
19,411
+11,919
| +159% | +$817K | 0.27% | 169 |
|
|
2019
Q2 | $545K | Buy |
7,492
+4,985
| +199% | +$392K | 0.1% | 240 |
|
|
2019
Q1 | $202K | Buy |
2,507
+2,462
| +5,471% | +$201K | 0.04% | 281 |
|
|
2018
Q4 | $4K | Sell |
45
-147
| -77% | -$12.9K | ﹤0.01% | 416 |
|
|
2018
Q3 | $18K | Buy |
+192
| New | +$18.2K | ﹤0.01% | 386 |
|
|
2018
Q2 | – | Sell |
-21,421
| Closed | -$2.03M | – | 241 |
|
|
2018
Q1 | $2.03M | Sell |
21,421
-75,491
| -78% | -$8.29M | 0.49% | 32 |
|
|
2017
Q4 | $9.37M | Sell |
96,912
-33,785
| -26% | -$3.18M | 2.2% | 18 |
|
|
2017
Q3 | $11.6M | Buy |
130,697
+7,336
| +6% | +$558K | 2.86% | 15 |
|
|
2017
Q2 | $8.95M | Buy |
123,361
+25,275
| +26% | +$1.7M | 2.23% | 17 |
|
|
2017
Q1 | $6.39M | Buy |
98,086
+66,992
| +215% | +$4.21M | 1.69% | 18 |
|
|
2016
Q4 | $1.95M | Buy |
+31,094
| New | +$1.9M | 0.55% | 38 |
|
Other funds holding ABBV
Fort LP's ABBV Position: Q3 2024 in Review
Fort LP reduced its AbbVie (ABBV) stake by 6.7% in Q3 2024, selling an estimated $23.9K and leaving 1,776 shares worth $351K. The position accounts for 0.89% of the portfolio, ranked #8.
Fort LP first reported a position in ABBV in Q4 2016 and has held it in 31 quarters since. The position peaked at $11.6M in Q3 2017. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.
- Fort LP held 1,776 shares of AbbVie worth $351K as of Q3 2024.
- Fort LP sold 128 AbbVie shares in Q3 2024, an estimated $23.9K.
- AbbVie made up 0.89% of Fort LP's portfolio in Q3 2024, its #8 holding.
- Fort LP first reported a position in AbbVie in Q4 2016 and has held it in 31 quarters since.
- Fort LP's AbbVie position peaked at $11.6M in Q3 2017.
- 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.
Based on Fort LP's 13F filing for Q3 2024, filed 29 Oct 2024.